Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

COVID-19 infection may trigger alopecia areata in some patients.

The evidence for using Low-Level Laser Therapy for hair loss is limited and more thorough research is needed.

New hair transplant methods offer more natural results and better graft survival, with ongoing research to increase donor hair options.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Hair restoration surgery effectively treats hair loss with natural-looking results, using techniques like stem cells and platelet-rich plasma.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Using a special laser can improve how well hair loss treatments get into the skin and hair follicles.

Menopause affects hair and skin; more research needed for treatment.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Laser and minoxidil combo promotes better hair growth than minoxidil alone, safely.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Smartphone-based teledermatology is effective for diagnosing skin diseases in the military with good accuracy.

Subcutaneous contraceptives can cause side effects like menstrual changes, headaches, weight gain, and pain at the implant site.

Every elderly patient had at least one skin condition, often linked to other diseases, highlighting the need for integrated skin and general healthcare in the elderly.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.